Literature DB >> 23204460

Use of a mariner-based transposon mutagenesis system to isolate Clostridium perfringens mutants deficient in gliding motility.

Hualan Liu1, Laurent Bouillaut, Abraham L Sonenshein, Stephen B Melville.   

Abstract

Clostridium perfringens is an anaerobic Gram-positive pathogen that causes many human and animal diseases, including food poisoning and gas gangrene. C. perfringens lacks flagella but possesses type IV pili (TFP). We have previously shown that C. perfringens can glide across an agar surface in long filaments composed of individual bacteria attached end to end and that two TFP-associated proteins, PilT and PilC, are needed for this. To discover additional gene products that play a role in gliding, we developed a plasmid-based mariner transposon mutagenesis system that works effectively in C. perfringens. More than 10,000 clones were screened for mutants that lacked the ability to move away from the edge of a colony. Twenty-four mutants (0.24%) were identified that fit the criteria. The genes containing insertions that affected gliding motility fell into nine different categories. One gene, CPE0278, which encodes a homolog of the SagA cell wall-dependent endopeptidase, acquired distinct transposon insertions in two independent mutants. sagA mutants were unable to form filaments due to a complete lack of end-to-end connections essential for gliding motility. Complementation of the sagA mutants with a wild-type copy of the gene restored gliding motility. We constructed an in-frame deletion mutation in the sagA gene and found that this mutant had a phenotype similar to those of the transposon mutants. We hypothesize that the sagA mutant strains are unable to form the molecular complexes which are needed to keep the cells in an end-to-end orientation, leading to separation of daughter cells and the inability to carry out gliding motility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23204460      PMCID: PMC3554012          DOI: 10.1128/JB.01288-12

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  24 in total

Review 1.  Virulence genes of Clostridium perfringens.

Authors:  J I Rood
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

2.  Isolation of alpha-toxin, theta-toxin and kappa-toxin mutants of Clostridium perfringens by Tn916 mutagenesis.

Authors:  M M Awad; J I Rood
Journal:  Microb Pathog       Date:  1997-05       Impact factor: 3.738

3.  Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens.

Authors:  Garry S A Myers; David A Rasko; Jackie K Cheung; Jacques Ravel; Rekha Seshadri; Robert T DeBoy; Qinghu Ren; John Varga; Milena M Awad; Lauren M Brinkac; Sean C Daugherty; Daniel H Haft; Robert J Dodson; Ramana Madupu; William C Nelson; M J Rosovitz; Steven A Sullivan; Hoda Khouri; George I Dimitrov; Kisha L Watkins; Stephanie Mulligan; Jonathan Benton; Diana Radune; Derek J Fisher; Helen S Atkins; Tom Hiscox; B Helen Jost; Stephen J Billington; J Glenn Songer; Bruce A McClane; Richard W Titball; Julian I Rood; Stephen B Melville; Ian T Paulsen
Journal:  Genome Res       Date:  2006-07-06       Impact factor: 9.043

4.  A purified mariner transposase is sufficient to mediate transposition in vitro.

Authors:  D J Lampe; M E Churchill; H M Robertson
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

5.  Type IV pili-dependent gliding motility in the Gram-positive pathogen Clostridium perfringens and other Clostridia.

Authors:  John J Varga; Van Nguyen; David K O'Brien; Katherine Rodgers; Richard A Walker; Stephen B Melville
Journal:  Mol Microbiol       Date:  2006-09-25       Impact factor: 3.501

6.  Carbon catabolite repression of type IV pilus-dependent gliding motility in the anaerobic pathogen Clostridium perfringens.

Authors:  Marcelo Mendez; I-Hsiu Huang; Kaori Ohtani; Roberto Grau; Tohru Shimizu; Mahfuzur R Sarker
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

7.  Generation of single-copy transposon insertions in Clostridium perfringens by electroporation of phage mu DNA transposition complexes.

Authors:  A Lanckriet; L Timbermont; L J Happonen; M I Pajunen; F Pasmans; F Haesebrouck; R Ducatelle; H Savilahti; F Van Immerseel
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

8.  A defined transposon mutant library and its use in identifying motility genes in Vibrio cholerae.

Authors:  D Ewen Cameron; Jonathan M Urbach; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-23       Impact factor: 11.205

9.  A mycobacterial operon essential for virulence in vivo and invasion and intracellular persistence in macrophages.

Authors:  Lian-Yong Gao; Melissa Pak; Rabab Kish; Kimberly Kajihara; Eric J Brown
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

10.  A mycobacterial enzyme essential for cell division synergizes with resuscitation-promoting factor.

Authors:  Erik C Hett; Michael C Chao; Lynn L Deng; Eric J Rubin
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

View more
  19 in total

Review 1.  Type IV pili in Gram-positive bacteria.

Authors:  Stephen Melville; Lisa Craig
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

2.  Role of the global regulator Rex in control of NAD+ -regeneration in Clostridioides (Clostridium) difficile.

Authors:  Laurent Bouillaut; Thomas Dubois; Michael B Francis; Nadine Daou; Marc Monot; Joseph A Sorg; Abraham L Sonenshein; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2019-04-02       Impact factor: 3.501

3.  An atypical lipoteichoic acid from Clostridium perfringens elicits a broadly cross-reactive and protective immune response.

Authors:  Cory Q Wenzel; Dominic C Mills; Justyna M Dobruchowska; Jiri Vlach; Harald Nothaft; Patrick Nation; Parastoo Azadi; Stephen B Melville; Russell W Carlson; Mario F Feldman; Christine M Szymanski
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

4.  Assessing Travel Conditions: Environmental and Host Influences On Bacterial Surface Motility.

Authors:  Anne E Mattingly; Abigail A Weaver; Aleksandar Dimkovikj; Joshua D Shrout
Journal:  J Bacteriol       Date:  2018-03-19       Impact factor: 3.490

5.  Cyclic Di-GMP Binding by an Assembly ATPase (PilB2) and Control of Type IV Pilin Polymerization in the Gram-Positive Pathogen Clostridium perfringens.

Authors:  William A Hendrick; Mona W Orr; Samantha R Murray; Vincent T Lee; Stephen B Melville
Journal:  J Bacteriol       Date:  2017-04-25       Impact factor: 3.490

6.  Identification of a proton-chloride antiporter (EriC) by Himar1 transposon mutagenesis in Lactobacillus reuteri and its role in histamine production.

Authors:  P Hemarajata; J K Spinler; M A Balderas; J Versalovic
Journal:  Antonie Van Leeuwenhoek       Date:  2014-02-01       Impact factor: 2.271

7.  Mechanical limitation of bacterial motility mediated by growing cell chains.

Authors:  Sean G McMahon; Stephen B Melville; Jing Chen
Journal:  Biophys J       Date:  2022-05-18       Impact factor: 3.699

8.  Hypermotility in Clostridium perfringens strain SM101 is due to spontaneous mutations in genes linked to cell division.

Authors:  Hualan Liu; Kristin D McCord; Jonathon Howarth; David L Popham; Roderick V Jensen; Stephen B Melville
Journal:  J Bacteriol       Date:  2014-04-18       Impact factor: 3.490

9.  A Transposon Mutagenesis System for Bifidobacterium longum subsp. longum Based on an IS3 Family Insertion Sequence, ISBlo11.

Authors:  Mikiyasu Sakanaka; Shingo Nakakawaji; Shin Nakajima; Satoru Fukiya; Arisa Abe; Wataru Saburi; Haruhide Mori; Atsushi Yokota
Journal:  Appl Environ Microbiol       Date:  2018-08-17       Impact factor: 4.792

10.  Transposon mutagenesis in Bifidobacterium breve: construction and characterization of a Tn5 transposon mutant library for Bifidobacterium breve UCC2003.

Authors:  Lorena Ruiz; Mary O'Connell Motherway; Noreen Lanigan; Douwe van Sinderen
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.